Dermatology Times
JULY 14, 2024
Andrea Zaenglein, MD, discussed the role of patient counseling and addressing "hormone phobia" in young patients treated with hormonal therapies for acne in her SPD 2024 session.
The Dermatology Digest
JULY 14, 2024
CUTISS AG’s denovoSkin performed well in a Phase 2 clinical trial of patients undergoing reconstructive skin surgery for various conditions, according to an interim analysis of the data. The full data analysis with the one year follow up will be available in early 2025. DenovoSkin is a personalized, bio-engineered dermo-epidermal human skin graft, created from a small biopsy of the patient’s healthy skin and expanded to produce large quantities of new skin.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Dermatology Times
JULY 14, 2024
TMB-001 0.05% demonstrates promising efficacy and safety in treating moderate to severe congenital ichthyosis, according to a poster presented at the SPD's annual meeting.
Alison Bladh
JULY 14, 2024
Skin Ageing: Nutrition Secrets to Slow It Down Ageing is inevitable, but as a nutritional therapist and beauty therapist, I understand the desire to maintain our youthful glow for as long as possible. Our skin, being the most exposed organ, shows the most visible signs of ageing. So, how can we keep it radiant and healthy throughout the years? Understanding Skin Ageing Ageing comes in two forms: intrinsic and extrinsic.
Dermatology Times
JULY 14, 2024
Browning discusses his participation in an SPD 2024 panel discussion, the future of pediatric dermatology, and more.
Aesthetics Advisor
JULY 14, 2024
Neotame, an artificial sweetener that’s chemically similar to aspartame, 1 may seriously damage the human intestine and overall gut health. 2 Sometimes listed on food ingredient labels as E961, neotame is a relative newcomer to the artificial sweetener market, despite well-known health concerns, is expected to reach a global market value of $3 billion by the end of 2025. 3 Neotame, developed in 2002 as an alternative to aspartame, is up to 13,000 times sweeter than sugar 4 and widely used in dri
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
Dermatology Times
JULY 14, 2024
Swanson discusses her SPD 2024 non-CME talk, expanding topical options for young patients, and more.
Dermatology Times
JULY 14, 2024
Catch up on coverage from the third and final day of the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada.
Dermatology Times
JULY 14, 2024
Tapinarof cream 1% has proven to be an effective and safe treatment for atopic dermatitis in diverse populations, according to a poster presented at the SPD's annual meeting.
Dermatology Times
JULY 14, 2024
Nnena Agim, MD, presented a comprehensive update on non-steroidal topical therapies, highlighting off-label uses and recent FDA approvals in a session at the SPD's annual meeting.
Expert insights. Personalized for you.
81 
Let's personalize your content